The rostromedial tegmental (RMTg) "brake" on dopamine and behavior: A decade of progress but also much unfinished work

Neuropharmacology. 2021 Oct 15:198:108763. doi: 10.1016/j.neuropharm.2021.108763. Epub 2021 Aug 22.

Abstract

Between 2005 and 2009, several research groups identified a strikingly dense inhibitory input to midbrain dopamine neurons arising from a previously uncharted region posterior to the ventral tegmental area (VTA). This region is now denoted as either the rostromedial tegmental nucleus (RMTg) or the "tail of the VTA" (tVTA), and is recognized to express distinct genetic markers, encode negative "prediction errors" (inverse to dopamine neurons), and play critical roles in behavioral inhibition and punishment learning. RMTg neurons are also influenced by many categories of abused drugs, and may drive some aversive responses to such drugs, particularly cocaine and alcohol. However, despite much progress, many important questions remain about RMTg molecular/genetic properties, diversity of projection targets, and applications to addiction, depression, and other neuropsychiatric disorders. This article is part of the special Issue on 'Neurocircuitry Modulating Drug and Alcohol Abuse'.

Keywords: Addiction; Habenula; RMTg.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Behavior / physiology*
  • Behavior, Animal / physiology*
  • Dopamine / physiology*
  • Dopaminergic Neurons / physiology
  • Humans
  • Substance-Related Disorders / physiopathology
  • Substance-Related Disorders / psychology
  • Tegmentum Mesencephali / drug effects
  • Ventral Tegmental Area / physiology*
  • Ventral Tegmental Area / physiopathology

Substances

  • Dopamine